EGFR and carcinoma: In numerous carcinomas, E-cadherin shows tumor-suppressing activities, while in inflammatory breast, ovarian, and squamous carcinomas, E-cadherin has been described to lead to tumor-promoting microembolus formation and prolonged survival via EGFR signaling [69].